214 related articles for article (PubMed ID: 21864313)
1. A naturally occurring naringenin derivative exerts potent bone anabolic effects by mimicking oestrogen action on osteoblasts.
Swarnkar G; Sharan K; Siddiqui JA; Mishra JS; Khan K; Khan MP; Gupta V; Rawat P; Maurya R; Dwivedi AK; Sanyal S; Chattopadhyay N
Br J Pharmacol; 2012 Mar; 165(5):1526-42. PubMed ID: 21864313
[TBL] [Abstract][Full Text] [Related]
2. Isoformononetin, a methoxydaidzein present in medicinal plants, reverses bone loss in osteopenic rats and exerts bone anabolic action by preventing osteoblast apoptosis.
Srivastava K; Tyagi AM; Khan K; Dixit M; Lahiri S; Kumar A; Changkija B; Khan MP; Nagar GK; Yadav DK; Maurya R; Singh SP; Jain GK; Wahajuddin ; Trivedi R; Chattopadhyay N; Singh D
Phytomedicine; 2013 Apr; 20(6):470-80. PubMed ID: 23395215
[TBL] [Abstract][Full Text] [Related]
3. A naturally occurring rare analog of quercetin promotes peak bone mass achievement and exerts anabolic effect on osteoporotic bone.
Siddiqui JA; Swarnkar G; Sharan K; Chakravarti B; Gautam AK; Rawat P; Kumar M; Gupta V; Manickavasagam L; Dwivedi AK; Maurya R; Chattopadhyay N
Osteoporos Int; 2011 Dec; 22(12):3013-27. PubMed ID: 21225417
[TBL] [Abstract][Full Text] [Related]
4. A novel flavonoid C-glucoside from Ulmus wallichiana preserves bone mineral density, microarchitecture and biomechanical properties in the presence of glucocorticoid by promoting osteoblast survival: a comparative study with human parathyroid hormone.
Khan MP; Mishra JS; Sharan K; Yadav M; Singh AK; Srivastava A; Kumar S; Bhaduaria S; Maurya R; Sanyal S; Chattopadhyay N
Phytomedicine; 2013 Nov; 20(14):1256-66. PubMed ID: 23928508
[TBL] [Abstract][Full Text] [Related]
5. Naringin improves bone properties in ovariectomized mice and exerts oestrogen-like activities in rat osteoblast-like (UMR-106) cells.
Pang WY; Wang XL; Mok SK; Lai WP; Chow HK; Leung PC; Yao XS; Wong MS
Br J Pharmacol; 2010 Apr; 159(8):1693-1703. PubMed ID: 20397301
[TBL] [Abstract][Full Text] [Related]
6. A novel quercetin analogue from a medicinal plant promotes peak bone mass achievement and bone healing after injury and exerts an anabolic effect on osteoporotic bone: the role of aryl hydrocarbon receptor as a mediator of osteogenic action.
Sharan K; Mishra JS; Swarnkar G; Siddiqui JA; Khan K; Kumari R; Rawat P; Maurya R; Sanyal S; Chattopadhyay N
J Bone Miner Res; 2011 Sep; 26(9):2096-111. PubMed ID: 21638315
[TBL] [Abstract][Full Text] [Related]
7. A comparative study of the bone metabolic response to dried plum supplementation and PTH treatment in adult, osteopenic ovariectomized rat.
Smith BJ; Bu SY; Wang Y; Rendina E; Lim YF; Marlow D; Clarke SL; Cullen DM; Lucas EA
Bone; 2014 Jan; 58():151-9. PubMed ID: 24125756
[TBL] [Abstract][Full Text] [Related]
8. Positive skeletal effects of cladrin, a naturally occurring dimethoxydaidzein, in osteopenic rats that were maintained after treatment discontinuation.
Khan K; Sharan K; Swarnkar G; Chakravarti B; Mittal M; Barbhuyan TK; China SP; Khan MP; Nagar GK; Yadav D; Dixit P; Maurya R; Chattopadhyay N
Osteoporos Int; 2013 Apr; 24(4):1455-70. PubMed ID: 22932734
[TBL] [Abstract][Full Text] [Related]
9. Parathyroid hormone restores bone mass and enhances osteoblast insulin-like growth factor I gene expression in ovariectomized rats.
Watson P; Lazowski D; Han V; Fraher L; Steer B; Hodsman A
Bone; 1995 Mar; 16(3):357-65. PubMed ID: 7786639
[TBL] [Abstract][Full Text] [Related]
10. 3-Piperidylethoxypterocarpan: A potential bone anabolic agent that improves bone quality and restores trabecular micro-architecture in ovariectomized osteopenic rats.
Raghuvanshi A; Kumar A; Tyagi AM; Kureel J; Awasthi P; Purohit D; Mansoori MN; Shukla P; Srivastava K; Gautam AK; Saxena R; Dwivedi A; Singh D; Goel A
Mol Cell Endocrinol; 2017 Jun; 448():41-54. PubMed ID: 28288902
[TBL] [Abstract][Full Text] [Related]
11. Effects of yuja peel extract and its flavanones on osteopenia in ovariectomized rats and osteoblast differentiation.
Jeon EJ; Lee DH; Kim YJ; Ahn J; Kim MJ; Hwang JT; Hur J; Kim M; Jang YJ; Ha TY; Seo DH; Lee JS; Sung MJ; Jung CH
Mol Nutr Food Res; 2016 Dec; 60(12):2587-2601. PubMed ID: 27506630
[TBL] [Abstract][Full Text] [Related]
12. Estrogen modulates estrogen receptor alpha and beta expression, osteogenic activity, and apoptosis in mesenchymal stem cells (MSCs) of osteoporotic mice.
Zhou S; Zilberman Y; Wassermann K; Bain SD; Sadovsky Y; Gazit D
J Cell Biochem Suppl; 2001; Suppl 36():144-55. PubMed ID: 11455579
[TBL] [Abstract][Full Text] [Related]
13. Icariin protects against bone loss induced by oestrogen deficiency and activates oestrogen receptor-dependent osteoblastic functions in UMR 106 cells.
Mok SK; Chen WF; Lai WP; Leung PC; Wang XL; Yao XS; Wong MS
Br J Pharmacol; 2010 Feb; 159(4):939-49. PubMed ID: 20128811
[TBL] [Abstract][Full Text] [Related]
14. Medicarpin, a legume phytoalexin, stimulates osteoblast differentiation and promotes peak bone mass achievement in rats: evidence for estrogen receptor β-mediated osteogenic action of medicarpin.
Bhargavan B; Singh D; Gautam AK; Mishra JS; Kumar A; Goel A; Dixit M; Pandey R; Manickavasagam L; Dwivedi SD; Chakravarti B; Jain GK; Ramachandran R; Maurya R; Trivedi A; Chattopadhyay N; Sanyal S
J Nutr Biochem; 2012 Jan; 23(1):27-38. PubMed ID: 21333515
[TBL] [Abstract][Full Text] [Related]
15. Osthole stimulates osteoblast differentiation and bone formation by activation of beta-catenin-BMP signaling.
Tang DZ; Hou W; Zhou Q; Zhang M; Holz J; Sheu TJ; Li TF; Cheng SD; Shi Q; Harris SE; Chen D; Wang YJ
J Bone Miner Res; 2010 Jun; 25(6):1234-45. PubMed ID: 20200936
[TBL] [Abstract][Full Text] [Related]
16. Maintenance of cancellous bone in ovariectomized, human parathyroid hormone [hPTH(1-84)]-treated rats by estrogen, risedronate, or reduced hPTH.
Iwaniec UT; Samnegård E; Cullen DM; Kimmel DB
Bone; 2001 Oct; 29(4):352-60. PubMed ID: 11595618
[TBL] [Abstract][Full Text] [Related]
17. Low-dose PTH increases osteoblast activity via decreased Mef2c/Sost in senescent osteopenic mice.
Saidak Z; Le Henaff C; Azzi S; Marty C; Marie PJ
J Endocrinol; 2014 Oct; 223(1):25-33. PubMed ID: 25056116
[TBL] [Abstract][Full Text] [Related]
18. Intermittent Fugu parathyroid hormone 1 (1-34) is an anabolic bone agent in young male rats and osteopenic ovariectomized rats.
McManus JF; Davey RA; Maclean HE; Doust EA; Chiu WS; Sims NA; Bouxsein ML; Glatt V; Zajac JD; Danks JA
Bone; 2008 Jun; 42(6):1164-74. PubMed ID: 18387351
[TBL] [Abstract][Full Text] [Related]
19. In vivo efficacy studies of layer-by-layer nano-matrix bearing kaempferol for the conditions of osteoporosis: a study in ovariectomized rat model.
Kumar A; Gupta GK; Khedgikar V; Gautam J; Kushwaha P; Changkija B; Nagar GK; Gupta V; Verma A; Dwivedi AK; Chattopadhyay N; Mishra PR; Trivedi R
Eur J Pharm Biopharm; 2012 Nov; 82(3):508-17. PubMed ID: 22926146
[TBL] [Abstract][Full Text] [Related]
20. Sequential treatment with basic fibroblast growth factor and PTH is more efficacious than treatment with PTH alone for increasing vertebral bone mass and strength in osteopenic ovariectomized rats.
Iwaniec UT; Mosekilde L; Mitova-Caneva NG; Thomsen JS; Wronski TJ
Endocrinology; 2002 Jul; 143(7):2515-26. PubMed ID: 12072383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
